Acute Aspirin Plus Cilostazol Dual Therapy for Noncardioembolic Stroke Patients Within 48 Hours of Symptom Onset

BACKGROUND: The aim of the present study was to investigate the efficacy and safety of antiplatelet (aspirin plus cilostazol) dual therapy for patients with noncardioembolic stroke within 48 hours of symptom onset. METHODS AND RESULTS: The ADS (Acute Aspirin Plus Cilostazol Dual Therapy for Non‐Card...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoki, Junya, Iguchi, Yasuyuki, Urabe, Takao, Yamagami, Hiroshi, Todo, Kenichi, Fujimoto, Shigeru, Idomari, Koji, Kaneko, Nobuyuki, Iwanaga, Takeshi, Terasaki, Tadashi, Tanaka, Ryota, Yamamoto, Nobuaki, Tsujino, Akira, Nomura, Koichi, Abe, Koji, Uno, Masaaki, Okada, Yasushi, Matsuoka, Hideki, Yamagata, Sen, Yamamoto, Yasumasa, Yonehara, Toshiro, Inoue, Takeshi, Yagita, Yoshiki, Kimura, Kazumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761671/
https://www.ncbi.nlm.nih.gov/pubmed/31347430
http://dx.doi.org/10.1161/JAHA.119.012652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761671/
https://www.ncbi.nlm.nih.gov/pubmed/31347430
http://dx.doi.org/10.1161/JAHA.119.012652

Ejemplares similares